Single-cell sequencing from the TISCH2 database showed CCL26’s broad distribution across various cell types, including tumor cells, mesenchymal stromal cells, and immune cells in head and neck cancers (Figure 2B) (GSE103322). This evidence concerns the gene CCL26 and head and neck cancer.